Alexion Loses in Patent Push for Blockbuster Drug Soliris – Barron’s

Alexion Loses in Patent Push for Blockbuster Drug Soliris  Barron’s

Bad news came for biotech firm Alexion Pharmaceuticals on Thursday night, but investors were ready, and the stock didn’t stumble. The European Patent Office …